Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].
IL-11 in multiple sclerosis.
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition.
Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation.
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population.
Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care.
G protein-coupled receptor kinase 2 moderates recruitment of THP-1 cells to the endothelium by limiting histamine-invoked Weibel-Palade body exocytosis.
Neuromyelitis optica spectrum disorders without and with autoimmune diseases.
Modern communication technology skills of patients with multiple sclerosis.
Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.
Female sex hormones and cytokine secretion in women with multiple sclerosis.
The link between resting-state functional connectivity and cognition in MS patients.
Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.
Clinical Manifestations and Spinal Cord Magnetic Resonance Imaging Findings in Chinese Neuromyelitis Optica Patients.
PAMP-DAMPs interactions mediates development and progression of multiple sclerosis.
Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.
Neuropathology of JC virus infection in progressive multifocal leukoencephalopathy in remission.
Trefoil factor 3 shows anti-inflammatory effects on activated microglia.
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.
Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis?
Orofaryngeale slikstoornissen bij neurodegeneratieve aandoeningen.
Long-term effectiveness of combined cognitive-behavioral and neuropsychological intervention in a case of multiple sclerosis.
Pages
« first
‹ previous
…
636
637
638
639
640
641
642
643
644
…
next ›
last »